Sterling Biotech Ltd

NSE : STERLINBIO

BSE: 512299

SECTOR : CHEMICALS

This stock is currently suspended from BSE

52w high/low	₹0.75 / ₹0
P/E ratio	0
Dividend	0
ROE	-18.32
ROCE	454.86
Face value	1
Book value	₹10.38Cr
Market capital	₹20.96Cr

Shareholding pattern

What is shareholding pattern? Who are shareholders?

Shareholding pattern represents the percentage of share ownership that different investors are holding in the company. A company can have multiple investors who invest in its shares. These are called as shareholders and there are two major categories of shareholders - promoters and public shareholders.

Promoters are typically the founders and public shareholders could be financial institutes like banks, insurance companies, domestic institutional investors, foreign institutional investors and common public.

Cash flow

What is a cash flow statement?

It is a financial statement that offers aggregate statistics on all cash inflows a business collects from its continuing activities and external sources of investment. It also includes all cash outflows over a specified time paying for company operations and investments.The main components of the CFS are cash from three areas: operating, investing, and financing activities...Read more

Balance Sheet

What is a balance sheet?

A balance sheet is a financial statement that records the assets, liabilities, and equity of a company at a certain point in time and provides a basis for estimating return rates and determining the capital structure. It offers a snapshot of what an entity owns and owes, as well as the sum that shareholders spend.The balance sheet complies with the following accounting equation in which assets on the one side, and liabilities plus shareholders' equity on the other, balance out:

Assets = Liabilities + Shareholder's Equity

This is used to conduct fundamental analysis or the estimation of financial ratios alongside other essential financial statements, such as income statement and statement of cash flows...Read more

Profit and loss

What is a profit and loss statement?

A profit and loss statement is a financial statement that represents the revenues, costs and expenses that the company has incurred during a quater or a fiscal year. It is also sometimes referred to as statement of profit and loss, income statement or statement of operations. This statement basically shows the investors and management whether the company has incurred profits or losses and in which areas.

Key Ratios

P/B

0.07

ROE

-18.32

ROCE

454.86

EBTIDA Growth

14294.14

D/E

-0.99

Sector PE

54.58

₹10.38Cr

Peer Comparison

Dividends

What are dividends?

Dividend, in financial terms, means a certain amount shared with shareholders of a company or a mutual fund on a regular basis – monthly, quarterly or annually. Read more

Bonuses

What are bonuses?

A bonus issue is an offer given to the existing shareholders of the company to subscribe for additional shares. Instead of increasing the dividend payout, the companies off... Read more

Company News

Sorry, we do not have any data here.

Sector News

Sorry, we do not have any data here.

About Sterling Biotech Ltd

Sterling Biotech Limited (SBL) was incorporated in 23rd March of the year 1985 in Mumbai as Pluto Exports & Consultants Limited and obtained its Certificate of Commencement of Business in 19th April of the same year 1985. SBL is engaged in producing pharmaceutical and nutraceutical gelatin in India and Asia. Additionally, Sterling sells dicalcium phosphate (DCP), a by-product of the gelatin manufacturing process, to poultry-feed and fertilizer industry in India. Sterling began its operations as a trading company, changed its focus to the manufacture of tea in the year 1991 and further changed its name to Sterling Tea and Industries Limited in 24th June of the year 1991. Its name was subsequently changed to Sterling Biotech Limited with effect from 29th March. In the year 1995, as part of an overall growth strategy Sterling's management identified gelatine as a high niche and a high growth area and the company also made a technical collaboration with Croda Colloids Limited of the United Kingdom in the same year 1995. In 1997, SDL had diversified into the production of pharmaceutical grade gelatine. SDL had successfully commissioned its first gelatine production facility in the same year, with an installed capacity of 2,200 MT, at Karakhadi, Dist Vadadora.